These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25331666)

  • 1. [Increased risk of hepatocellular carcinoma in patients with chronic hepatitis C].
    Hallager S; Weis N
    Ugeskr Laeger; 2014 Oct; 176(41):. PubMed ID: 25331666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.
    Abdelaziz AO; Shousha HI; Said EM; Soliman ZA; Shehata AA; Nabil MM; Abdelmaksoud AH; Elbaz TM; Abdelsalam FM
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1384-1388. PubMed ID: 30179227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.
    Passos-Castilho AM; Lo Turco E; Ferraz ML; Matos C; Silva I; Parise E; Pilau E; Gozzo F; Granato C
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):43-9. PubMed ID: 25822433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers.
    Lee CH; Hsieh SY; Chang CJ; Lin YJ
    J Gastroenterol Hepatol; 2013 Jan; 28(1):122-7. PubMed ID: 23034166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C and hepatocellular carcinoma.
    Fassio E
    Ann Hepatol; 2010; 9 Suppl():119-22. PubMed ID: 20714008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.
    Abdel-Razik A; Elhelaly R; Elzehery R; El-Diasty A; Abed S; Elhammady D; Tawfik A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):599-605. PubMed ID: 26741637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease.
    Trinchet JC; Ganne-Carrié N; Nahon P; N'kontchou G; Beaugrand M
    World J Gastroenterol; 2007 May; 13(17):2455-60. PubMed ID: 17552029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma in HIV hepatitis C virus.
    Puoti M; Rossotti R; Garlaschelli A; Bruno R
    Curr Opin HIV AIDS; 2011 Nov; 6(6):534-8. PubMed ID: 21934618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment strategies of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antiviral drugs].
    Gao X; Ji FP
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):827-830. PubMed ID: 33105926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?
    Cabibbo G; Celsa C; Cammà C; Craxì A
    Liver Int; 2018 Dec; 38(12):2108-2116. PubMed ID: 29935096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: a case-control study.
    Hatzakis A; Katsoulidou A; Kaklamani E; Touloumi G; Koumantaki Y; Tassopoulos NC; Karvountzis G; Gioustozi A; Hadziyannis S; Trichopoulos D
    Int J Cancer; 1996 Sep; 68(1):51-3. PubMed ID: 8895540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic viruses and hepatocellular carcinoma.
    Ben Ari Z; Weitzman E; Safran M
    Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of pSmad2/3 and Smad4 in hepatitis C virus-related liver fibrosis and hepatocellular carcinoma.
    Moussa MM; Helal NS; Youssef MM
    APMIS; 2018 Jun; 126(6):477-485. PubMed ID: 29924446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of unfavorable prognosis of chronic hepatitis C.
    Shchanitcyna SE; Burnevich EZ; Nikulkina EN; Filatova AL; Мoiseev SV; Мukhin NA
    Ter Arkh; 2019 Mar; 91(2):59-66. PubMed ID: 31094173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
    Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
    J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus.
    Abdelwahab FA; Hassanein KM; Hetta HF; Abdelmalek MO; Zahran AM; El-Badawy O
    Sci Rep; 2020 Nov; 10(1):20383. PubMed ID: 33230233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral treatment for cirrhosis due to hepatitis C: a review.
    Somasundaram A; Venkataraman J
    Singapore Med J; 2012 Apr; 53(4):231-5. PubMed ID: 22511042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hepatitis C and screening for hepatocellular carcinoma.
    Sherman M
    Clin Liver Dis; 2006 Nov; 10(4):735-52. PubMed ID: 17164115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors.
    Wong A; Le A; Lee MH; Lin YJ; Nguyen P; Trinh S; Dang H; Nguyen MH
    Sci Rep; 2018 May; 8(1):7164. PubMed ID: 29740031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.